ABL	abl proto-oncogene
ALCL	anaplastic large cell lymphoma
ALK	anaplastic lymphoma kinase
BCR	breakpoint cluster region
BDNF	brain-derived neurotrophic factor
BRAF	B rapidly accelerated fibrosarcoma
CDx	companion diagnostics
CIPA	congenital insensitivity to pain with anhidrosis
CNS	central nervous system
ETV6	ETS variant transcription factor 6
FDA	food and drug administration
FGFR	fibroblast growth factor receptor
FISH	fluorescence in situ hybridization
HER2	human epidermal growth factor receptor 2
IC50	half maximal inhibitory concentration
IHC	immunohistochemistry
IMT	inflammatory myofibroblastic tumor
LMNA	lamin A/C
NGF	nerve growth factor
NGS	next-generation sequencing
NSCLC	non-small cell lung cancer
NTRK	neurotrophic tyrosine receptor kinase
ORR	overall response rate
PD-1	programmed cell death protein 1
RET	ret proto-oncogene
ROS1	c-ros proto-oncogene
RT-PCR	reverse transcriptase polymerase chain reaction
SRC	src proto-oncogene
TNK2	tyrosine kinase non receptor 2
TPM3	tropomyosin 3
TPR	translocated promoter region
TRIM24	tripartite motif containing 24
Trk	tropomyosin receptor kinase
xDFG	Aspartate-Phenylalanine-Glycine